Moderna halts development of birth defect vaccine after trial setback – Reuters
- Moderna halts development of birth defect vaccine after trial setback Reuters
- Moderna says key study of its CMV vaccine, expected to be its next big win, failed statnews.com
- Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint Yahoo Finance
- Moderna Drops Vaccine for Birth Defects After Trial Failure Barron’s
- Moderna Vaccine Fails to Prevent Infection Tied to Birth Defects Bloomberg.com